Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | 1 | IL-5 | 11.0 | 43 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL-5 | 10.0 | 66 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | IL-5 | 13.5 | 66 | ||||
RA2159 | EGF | 100 | ng/mL | 1 | IL-5 | 12.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 11.0 | 56 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 11.0 | 57 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.0 | 73 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.0 | 61 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.0 | 67 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | IL-5 | 12.0 | 94 | ||||
N2586 | EGF | 100 | ng/mL | 1 | IL-5 | 12.0 | 64 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 13.0 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 14.0 | 55 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.0 | 41 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-5 | 10.5 | 44 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | IL-5 | 12.0 | 66 | ||||
RA2159 | IGF-I | 100 | ug/mL | 1 | IL-5 | 9.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IL-5 | 10.0 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-5 | 9.0 | 43 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-5 | 8.0 | 71 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-5 | 11.0 | 99 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IL-5 | 10.0 | 78 | |
RA2159 | 1 | IL-5 | 10.0 | 65 | |||||||
N2586 | IGF-I | 100 | ug/mL | 1 | IL-5 | 11.0 | 52 |